AFFF Settlement Data: What Has Been Paid
The AFFF/PFAS litigation has already produced some of the largest environmental settlements in American history. On the water utility track, 3M agreed to pay $10.3 billion over 13 years to resolve claims from 300+ water systems (June 2023). DuPont, Chemours, and Corteva settled for $1.185 billion (approved February 2024). Tyco Fire Products (Johnson Controls) settled for $750 million (2024). BASF settled for $316.5 million (2024). These settlements — totaling over $12.5 billion — cover the costs of water testing, treatment, and remediation, not individual health claims.
The C8 personal injury settlements provide the most relevant precedent for the current MDL 2873 personal injury claims. Approximately 3,550 individual claims from residents exposed to PFOA from DuPont's Washington Works facility were settled for a combined $670.7 million — an average of approximately $189,000 per claim. These settlements followed three successful bellwether jury trials: Bartlett received $1.6 million for kidney cancer, Freeman received $5.1 million for testicular cancer, and Wolf received $12.5 million for testicular cancer. The Minnesota v. 3M settlement of $850 million (2018) for groundwater contamination provides additional context for the scale of PFAS liability.
The personal injury track in MDL 2873 represents a significantly larger plaintiff population than the C8 litigation — 15,216+ claims compared to approximately 3,550 in the C8 cases. The broader range of defendants, the higher contamination levels at many military sites, and the stronger regulatory landscape (IARC Group 1 classification, EPA MCL of 4 ppt) all suggest that MDL 2873 personal injury settlements could be substantial.
Projected Personal Injury Settlement Ranges
Based on the C8 precedent, the water utility settlement values, and comparable environmental mass tort benchmarks, three compensation tiers have been projected for MDL 2873 personal injury claims. Tier I (moderate) covers documented exposure with medical monitoring needs or early-stage diagnosis, with projected values of $25,000 to $100,000. Tier II (significant) covers cancer diagnoses linked to PFAS, firefighters with documented AFFF use history, and military personnel with base contamination evidence, with projected values of $100,000 to $500,000. Tier III (severe) covers advanced-stage cancer, wrongful death, and decades of direct occupational exposure, with projected values of $500,000 to $2 million or more.
Several factors will influence individual settlement values. The specific diagnosis is critical — kidney cancer and testicular cancer have the strongest causation science and command the highest valuations. The strength of exposure documentation matters significantly — blood PFAS testing, military service records, and fire department employment records provide direct evidence. The duration and intensity of exposure affect tier placement, with decades of occupational AFFF handling valued higher than shorter-term residential water exposure. The severity of the health outcome — early-stage versus advanced cancer, treatment complications, and impact on quality of life — determines the upper or lower end of each tier's range.
Filing early positions plaintiffs for the best outcomes. Bellwether trials establish valuation benchmarks that inform settlement negotiations for the remaining claims. Families and individuals who file before bellwether trials are included in any resulting settlement framework from the outset. The contingency fee structure means there is no cost to file — you pay nothing unless you recover compensation.
Scientific Evidence
Meta-Analysis of PFAS Exposure and Cancer Risk: Kidney and Testicular Cancer
Mastrantonio M, Bai E, Uccelli R, Cordiano V, Screpanti A, Corigliano P. (2023). La Medicina del Lavoro
Key Findings
- Relative risk of 1.74 for kidney cancer among individuals with high PFAS exposure compared to low-exposure controls
- Relative risk of 2.22 for testicular cancer among individuals with high PFAS exposure — the strongest relative risk of any PFAS-cancer association
- Dose-response relationship demonstrated: higher PFAS blood levels correlated with progressively higher cancer risk
- Results consistent across multiple study designs and populations, strengthening the causal inference
"The Devil They Knew": Industry Knowledge of PFAS Dangers Since 1970
Brennan NM, Evans AT, Fritz MK, Peak SA, von Holst HE. (2023). Annals of Global Health
Key Findings
- PFAS manufacturers knew about the persistence and toxicity of their products as early as 1970 — more than 50 years before widespread public awareness
- 3M conducted internal studies showing PFAS bioaccumulation in worker blood at 1,000 times normal levels and animal studies showing tumor formation, then classified results as confidential
- Manufacturers used trade secret protections and proprietary research agreements to prevent damaging findings from reaching regulators or the public
- The pattern of corporate concealment parallels the tobacco and asbestos industries and supports punitive damages claims based on willful and malicious conduct
C8 Science Panel: Probable Link Evaluations for PFOA-Associated Diseases
Fletcher T, Savitz D, Steenland K. (2012). Environmental Health Perspectives
Key Findings
- Determined "probable link" between PFOA exposure and six diseases: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension
- Study population of 69,000 residents made it one of the largest PFAS health studies ever conducted, providing exceptional statistical power
- Findings have been cited in virtually every subsequent PFAS lawsuit and regulatory action worldwide
- The "probable link" standard — requiring more than just association but less than definitive proof — was a negotiated scientific threshold that has become the benchmark for PFAS causation evidence
Frequently Asked Questions
Related Pages
3M & DuPont PFAS Lawsuit
3M and DuPont are the two primary defendants in the AFFF/PFAS litigation. 3M manufactured PFOS-based AFFF from the 1960s and has already paid $10.3 billion in water utility settlements and $850 million to Minnesota. DuPont manufactured PFOA and was the target of the landmark Bilott litigation that created the C8 Science Panel. Internal documents from both companies show they knew about PFAS toxicity for decades and concealed it. Their corporate successors — Chemours, Corteva, and others — share in the liability.
AFFF Firefighter Cancer Claims
Firefighters have the highest documented PFAS blood levels of any occupational group and form the core of the AFFF personal injury litigation. Municipal, airport, and military firefighters who trained with AFFF absorbed PFAS through skin contact and inhalation of foam mist, often for years or decades without protective equipment. NIOSH studies show elevated cancer rates among firefighters, and many states have enacted presumptive cancer laws that create favorable conditions for firefighter AFFF claims.
AFFF Kidney Cancer Lawsuit
Kidney cancer (renal cell carcinoma) has the strongest scientific link to PFAS exposure of any cancer. IARC classified PFOA as a Group 1 carcinogen based largely on kidney cancer evidence. Meta-analyses show a relative risk of 1.74 for kidney cancer at high PFAS exposure levels. The C8 Science Panel determined a "probable link" between PFOA and kidney cancer based on the 69,000-person Mid-Ohio Valley study. Firefighters and military personnel with kidney cancer and AFFF exposure history have among the strongest claims in MDL 2873.
AFFF Military Base Contamination
The Department of Defense has identified PFAS contamination at more than 455 military installations where AFFF was used for fire training and emergency response. Air Force bases, Naval air stations, and Marine Corps installations are the most heavily affected. Service members, their families, and surrounding communities were exposed for decades through contaminated drinking water. Military personnel can file AFFF lawsuits against the foam manufacturers while also receiving VA benefits.
AFFF Testicular Cancer Lawsuit
Testicular cancer has the highest relative risk of any PFAS-linked cancer, with meta-analyses showing RR=2.22 for high PFAS exposure — meaning more than double the cancer risk. The C8 Science Panel determined a "probable link" between PFOA and testicular cancer. Testicular cancer is most common in younger men (ages 15-35), making it particularly relevant for military personnel and younger firefighters exposed to AFFF early in their careers.
AFFF Thyroid Disease Lawsuit
Thyroid disease is one of six conditions with a C8 Science Panel "probable link" to PFOA exposure. PFAS are potent endocrine disruptors that interfere with thyroid hormone synthesis and metabolism, causing hypothyroidism, hyperthyroidism, and thyroid cancer. Thyroid disease is often the earliest clinical manifestation of PFAS exposure and may affect a broader population than PFAS-linked cancers, making it significant for the AFFF litigation.
AFFF Water Contamination Lawsuit
PFAS from AFFF have contaminated the drinking water of an estimated 100 million Americans. Water utility settlements exceeding $12.5 billion have been approved in MDL 2873, but personal injury claims from individuals who drank contaminated water remain active. The EPA's 2024 drinking water standard of 4 ppt for PFOA/PFOS confirmed that previously "safe" levels were actually harmful. Community residents who developed PFAS-linked diseases from contaminated water have viable personal injury claims.
AFFF Firefighting Foam Lawsuit
AFFF firefighting foam containing per- and polyfluoroalkyl substances (PFAS) has been used since the 1960s at military bases, airports, and fire training facilities across the United States. These "forever chemicals" do not break down in the environment and have contaminated groundwater, soil, and drinking water supplies serving millions of Americans. The C8 Science Panel established "probable links" between PFAS exposure and six diseases including kidney cancer, testicular cancer, and thyroid disease. MDL 2873, consolidated before Judge Richard Gergel in the District of South Carolina, encompasses over 15,216 personal injury claims against manufacturers including 3M, DuPont, Chemours, Tyco Fire Products, and BASF. Water utility settlements exceeding $12.5 billion have been approved, and the personal injury track is advancing toward bellwether trials with Daubert motions and expert depositions underway.
View full case overview